Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4]

Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed] It is also sold with tazarotene with 0.01% halobetasol and 0.045% tazarotene as a lotion branded as Duobrii (Bausch Health).

It is available as a generic medication.[5]

References

  1. ^ a b "Ultravate product monograph" (PDF). Retrieved 2021-01-04.
  2. ^ DrugBank DB00596 . Retrieved 2020-01-04.
  3. ^ Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB, Feldman SR (July 2004). "Class I topical corticosteroid use by psoriasis patients in an academic practice". The Journal of Dermatological Treatment. 15 (4): 235–8. doi:10.1080/09546630410033745. PMID 15764038. S2CID 2757493.
  4. ^ ATC code D07AC21 (WHO). Retrieved 2020-01-04.
  5. ^ "Ulobetasol international". Drugs.com. 10 August 2020. Retrieved 15 August 2020.
Allikas: https://en.wikipedia.org/wiki/Ulobetasol
No tags for this post.